- Home
- HFRO vs KRRO Comparison
HFRO vs KRRO Comparison
Compare HFRO & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFRO
- KRRO
- Stock Information
- Founded
- HFRO 2000
- KRRO 2014
- Country
- HFRO United States
- KRRO United States
- Employees
- HFRO N/A
- KRRO N/A
- Industry
- HFRO Finance/Investors Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- HFRO Finance
- KRRO Health Care
- Exchange
- HFRO Nasdaq
- KRRO Nasdaq
- Market Cap
- HFRO 362.0M
- KRRO 358.3M
- IPO Year
- HFRO N/A
- KRRO 2019
- Fundamental
- Price
- HFRO $6.51
- KRRO $51.36
- Analyst Decision
- HFRO
- KRRO Strong Buy
- Analyst Count
- HFRO 0
- KRRO 7
- Target Price
- HFRO N/A
- KRRO $96.71
- AVG Volume (30 Days)
- HFRO 179.8K
- KRRO 278.1K
- Earning Date
- HFRO 01-01-0001
- KRRO 11-11-2025
- Dividend Yield
- HFRO 8.87%
- KRRO N/A
- EPS Growth
- HFRO N/A
- KRRO N/A
- EPS
- HFRO N/A
- KRRO N/A
- Revenue
- HFRO N/A
- KRRO $6,281,000.00
- Revenue This Year
- HFRO N/A
- KRRO $116.91
- Revenue Next Year
- HFRO N/A
- KRRO N/A
- P/E Ratio
- HFRO N/A
- KRRO N/A
- Revenue Growth
- HFRO N/A
- KRRO N/A
- 52 Week Low
- HFRO $4.24
- KRRO $10.29
- 52 Week High
- HFRO $6.45
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- HFRO 57.12
- KRRO 66.93
- Support Level
- HFRO $6.18
- KRRO $40.70
- Resistance Level
- HFRO $6.63
- KRRO $47.55
- Average True Range (ATR)
- HFRO 0.17
- KRRO 5.36
- MACD
- HFRO -0.01
- KRRO -0.33
- Stochastic Oscillator
- HFRO 73.33
- KRRO 78.77
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.